About company
Vast Therapeutics develops inhalable treatments for antibiotic-resistant pathogens present in cystic fibrosis and other respiratory disease patients. The company is in the preclinical stage of developing inhalable therapeutics to treat chronic infections common to the cystic fibrosis population.
- US
- info@vasttherapeutics.com
- Unknown
- vasttherapeutics.com/
- Not verified company
